MOTS-C is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is researched primarily for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility. The first mitochondrial genome-encoded peptide to enter human testing — essentially exercise in a peptide, activating the same AMPK pathways triggered by physical training. It belongs to the Mitochondrial-derived peptide, metabolic regulator category of compounds.
What Is MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging.
The first mitochondrial genome-encoded peptide to enter human testing — essentially exercise in a peptide, activating the same AMPK pathways triggered by physical training. It has attracted significant research interest for its potential effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
How Does MOTS-C Produce These Benefits?
Translocates to the nucleus where it regulates gene expression through the Folate-AICAR-AMPK pathway. Activates antioxidant response elements (ARE) and interacts with NRF2 transcription factor to enhance cellular stress resistance. Improves insulin sensitivity and glucose metabolism through AMPK pathway activation, essentially mimicking exercise at the molecular level.
This multi-pathway activity is why MOTS-C shows potential across several different applications rather than being limited to a single use case.
Can MOTS-C Help With Improved Insulin Sensitivity?
Research suggests MOTS-C may support improved insulin sensitivity through its mitochondrial-derived peptide, metabolic regulator activity. First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
Protocols targeting improved insulin sensitivity typically use 5-10 mg per week administered 2-3 times weekly for 8-12 weeks with 8-12 week breaks.
Can MOTS-C Help With Glucose Metabolism?
Research suggests MOTS-C may support glucose metabolism through its mitochondrial-derived peptide, metabolic regulator activity. First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
Protocols targeting glucose metabolism typically use 5-10 mg per week administered 2-3 times weekly for 8-12 weeks with 8-12 week breaks.
Can MOTS-C Help With Fat Loss?
Research suggests MOTS-C may support fat loss through its mitochondrial-derived peptide, metabolic regulator activity. First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
Protocols targeting fat loss typically use 5-10 mg per week administered 2-3 times weekly for 8-12 weeks with 8-12 week breaks.
Can MOTS-C Help With Lean Muscle Preservation?
Research suggests MOTS-C may support lean muscle preservation through its mitochondrial-derived peptide, metabolic regulator activity. First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
Protocols targeting lean muscle preservation typically use 5-10 mg per week administered 2-3 times weekly for 8-12 weeks with 8-12 week breaks.
Can MOTS-C Help With Exercise Capacity Enhancement?
Research suggests MOTS-C may support exercise capacity enhancement through its mitochondrial-derived peptide, metabolic regulator activity. First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
Protocols targeting exercise capacity enhancement typically use 5-10 mg per week administered 2-3 times weekly for 8-12 weeks with 8-12 week breaks.
Can Stacking Enhance MOTS-C Benefits?
Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization.
See our MOTS-C stacking guide for detailed combination protocols.
What Is the Bottom Line on MOTS-C Benefits?
MOTS-C is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility. The evidence base includes: First mitochondrial-derived peptide to enter human trials — a 4-week trial of 20 subjects showed glucose reduction and liver enzyme improvement. Extensive animal research documents metabolic, anti-aging, and exercise benefits. Listed by FDA as not approved for compounding.
MOTS-C is not fda-approved. listed by fda as unlawful for compounding. available as research chemical only. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
MOTS-c: The Metabolic Mitochondrial Peptide
Related Reading
- MOTS-C Dosage Guide
- MOTS-C Side Effects
- MOTS-C Stacking Guide
- MOTS-C Cycle Guide
- MOTS-C Research
- 5-Amino-1MQ Complete Guide
Calculate Your MOTS-C Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MOTS-C.
Open Calculator →Research-Grade Sourcing
If you're going to research MOTS-C, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MOTS-C?
MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging. It is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.
What is the recommended MOTS-C dosage?
Common dosages: 5-10 mg per week administered 2-3 times weekly via subcutaneous injection. Cycle length: 8-12 weeks with 8-12 week breaks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of MOTS-C?
Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.
Is MOTS-C safe?
MOTS-C has shown a favorable safety profile in research. Not FDA-approved. Listed by FDA as unlawful for compounding. Available as research chemical only. All research should follow appropriate safety protocols.